Note 1 - The Company and Significant Accounting Policies (Details) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		6 Months Ended						7 Months Ended	0 Months Ended									8 Months Ended				3 Months Ended		6 Months Ended		3 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Apr. 19, 2013	Apr. 17, 2013	Mar. 31, 2013		Nov. 14, 2013 Subsequent Event [Member]	Mar. 02, 2013 Recapitalization [Member] Preferred Stock Other Than 1,075 Shares of Series C [Member] Convertible Notes [Member]	Apr. 19, 2013 Recapitalization [Member] Preferred Stock Other Than 1,075 Shares of Series C [Member]	Feb. 28, 2013 Recapitalization [Member] Preferred Stock Other Than 1,075 Shares of Series C [Member]	Mar. 02, 2013 Recapitalization [Member] Convertible Notes [Member]	Feb. 28, 2013 Recapitalization [Member] Convertible Notes [Member]	Feb. 28, 2013 Recapitalization [Member] Related Party Advances, Accrued Consulting Fees [Member]	Apr. 19, 2013 Recapitalization [Member] Related Party Advances [Member]	Mar. 02, 2013 Recapitalization [Member] Related Party Advances [Member]	Feb. 28, 2013 Recapitalization [Member] Related Party Advances [Member]	Sep. 30, 2013 Recapitalization [Member]	Feb. 01, 2013 Recapitalization [Member]	Sep. 30, 2013 Not Participate in the Recapitalization [Member] Series C Preferred Stock [Member]	Sep. 30, 2013 Series C Preferred Stock [Member]	Sep. 30, 2013 Sales Revenue, Net [Member]	Sep. 30, 2012 Sales Revenue, Net [Member]	Sep. 30, 2013 Sales Revenue, Net [Member]	Sep. 30, 2012 Sales Revenue, Net [Member]	Sep. 30, 2013 Accounts Receivable [Member]	Sep. 30, 2012 Accounts Receivable [Member]
Note 1 - The Company and Significant Accounting Policies (Details) [Line Items]
Number of Operating Segments			1
Retained Earnings (Accumulated Deficit) (in Dollars)	$ (117,634)		$ (117,634)				$ (116,465)	[1]
Additional Funding Required For Operating Needs (in Dollars)			1,200
Proceeds from Related Party Debt (in Dollars)									2,011
Concentration Risk, Number			1																				1	1		0	0	1
Concentration Risk, Percentage																							11.00%	13.00%	13.00%	10.00%	10.00%	11.00%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	3,018,347		3,018,000	1,457,000
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term			4 years	4 years
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized (in Dollars)	311		311
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, To Be Recognized This Fiscal Year (in Dollars)	75		75
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, To Be Recognized In Year 2 (in Dollars)	145		145
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, To Be Recognized In Year 3 (in Dollars)	77		77
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, To Be Recognized In Year 4 (in Dollars)	14		14
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)	$ 0.13	$ 0.01	$ 0.13	$ 0.01
Debt Instrument, Convertible, Conversion Price (in Dollars per share)																				$ 0.35
Preferred Stock, Shares Outstanding (in Shares)	1,075		1,075				8,141	[1]													1,075	1,075
Conversion of Stock, Shares Issued										17,614,655	20,556,569	28,158,852							72,900,000
Debt Conversion, Original Debt, Amount (in Dollars)													$ 3,504	$ 3,504	$ 158		$ 12,146	$ 12,146
Debt Conversion, Converted Instrument, Shares Issued (in Shares)														10,012,372		26,028,108	8,676,034	34,704,102
Conversion of Stock, Shares Converted											7,066	9,404
Common Stock, Shares Authorized	150,000,000		150,000,000		150,000,000	30,000,000	30,000,000	[1]

[1] Derived from the Company's audited consolidated financial statements. The accompanying notes are an integral part of these condensed consolidated financial statements.